2. Search Result
Search Result
Results for "

Val-val

" in MedChemExpress (MCE) Product Catalog:

14

Inhibitors & Agonists

5

Peptides

1

Inhibitory Antibodies

2

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-137367
    Z-Val-Val-Arg-AMC

    		Cathepsin Infection
    Z-Val-Val-Arg-AMC is a fluorescent peptide substrate that can be used to test the activity of cathepsins .
    Z-Val-Val-Arg-AMC
  • HY-16513
    VAL-083
    1 Publications Verification

    Dianhydrodulcitol; Dianhydrogalactitol

    		 DNA Alkylator/Crosslinker Cancer
    VAL-083 is an alkylating agent that creates N7 methylation on DNA, with antitumor activity.
    VAL-083
  • HY-103265
    ARL67156 trisodium
    2 Publications Verification

    FPL 67156 trisodium

    		 NTPDase Cardiovascular Disease Inflammation/Immunology
    ARL67156 (FPL 67156) trisodium is a selective small molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 trisodium is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with Kis of 11, 18 and 12?μM, respectively. ARL67156 trisodium can be used in the research of calcific aortic valve disease, asthma .
    ARL67156 trisodium
  • HY-126584
    H-Val-Val-OH

    val-val

    		 Biochemical Assay Reagents Others
    H-VAL-VAL-OH is a dipeptide of the amino acid valine, an essential amino acid .
    H-Val-Val-OH
  • HY-130956
    Boc-NMe-Val-Val-Dil-Dap-OH

    		ADC Linker Cancer
    Boc-NMe-Val-Val-Dil-Dap-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
    Boc-NMe-Val-Val-Dil-Dap-OH
  • HY-P4019
    Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2

    		HIV Protease Others
    Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 is a substrato peptídico of HIV-1 protease. Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 acts as the variable substrate in a peptidolytic assay to quantify the inhibition of the protease .
    Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2
  • HY-W250408
    Fmoc-NMe-Val-Val-Dil-Dap-OH

    		Drug-Linker Conjugates for ADC Cancer
    Fmoc-NMe-Val-Val-Dil-Dap-OH is an intermediate for preparing drug-linker conjugate MC-MMAF, which can be used for synthesis of ADC molecule .
    Fmoc-NMe-Val-Val-Dil-Dap-OH
  • HY-120164
    Glycerophospho-N-oleoyl ethanolamine

    GNOE

    		 Endogenous Metabolite Cardiovascular Disease
    Glycerophospho-N-oleoyl ethanolamine (GNOE) is a serum metabolite. Glycerophospho-N-oleoyl ethanolamine can be used to study Bicuspid aortic valve (BAV) disease .
    Glycerophospho-N-oleoyl ethanolamine
  • HY-P99803
    Clervonafusp alfa

    val-1221

    		 Glycosidase Others
    Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .
    Clervonafusp alfa
  • HY-116307
    2-Thio-UTP

    		P2Y Receptor Cardiovascular Disease
    2-Thio-UTP is a selective P2Y2 inhibitor with an EC50 value of 50 nM. 2-Thio-UTP reduces pro-fibrotic gene expression and protein α-smooth muscle actin. 2-Thio-UTP has the potential for the research of calcific aortic valve stenosis (CAVS) .
    2-Thio-UTP
  • HY-103265D
    ARL67156 triethylamine
    2 Publications Verification

    FPL 67156 triethylamine

    		 NTPDase Cardiovascular Disease Inflammation/Immunology
    ARL67156 (FPL 67156) triethylamine is a selective small is a selective samll molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 triethylamine is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with Kis of 11, 18 and 12 μM, respectively. ARL67156 triethylamine can be used in the research of disease like calcific aortic valve disease, asthma .
    ARL67156 triethylamine
  • HY-103265B
    ARL67156 trisodium hydrate
    2 Publications Verification

    FPL 67156 trisodium hydrate

    		 NTPDase Cardiovascular Disease Inflammation/Immunology
    ARL67156 (FPL 67156) trisodium hydrate is a selective small is a selective samll molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 trisodium hydrate is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with Kis of 11, 18 and 12?μM, respectively. ARL67156 trisodium hydrate can be used in the research of disease like calcific aortic valve disease, asthma .
    ARL67156 trisodium hydrate
  • HY-112499S
    Menaquinone-7-d7

    Vitamin K2-7-d7; Vitamin K2(35)-d7; Vitamin MK-7-d7

    		 Isotope-Labeled Compounds Cardiovascular Disease
    Menaquinone-7-d7 is the deuterium labeled Menaquinone-7. Menaquinone-7 (Vitamin K2-7), belongs to a class of K2-vitamin homologs, is originally discovered as the anti-hemorrhagic factors[1]. Menaquinone-7 (Vitamin K2-7) is identified as the most bioactive cofactor for the carboxylation reaction of Gla-proteins [2]. Supplementation with Menaquinone-7 (Vitamin K2-7) is a pharmacological option for activating matrix Gla protein and intervening in the progression of calcific aortic valve stenosis (CAVS)[3].
    Menaquinone-7-d7
  • HY-112499S1
    Menaquinone-7-13C6

    Vitamin K2-7-13C6; Vitamin K2(35)-13C6; Vitamin MK-7-13C6

    		 Isotope-Labeled Compounds Cardiovascular Disease
    Menaquinone-7- 13C6 is the 13C-labeled Menaquinone-7. Menaquinone-7 (Vitamin K2-7), belongs to a class of K2-vitamin homologs, is originally discovered as the anti-hemorrhagic factors[1]. Menaquinone-7 (Vitamin K2-7) is identified as the most bioactive cofactor for the carboxylation reaction of Gla-proteins [2]. Supplementation with Menaquinone-7 (Vitamin K2-7) is a pharmacological option for activating matrix Gla protein and intervening in the progression of calcific aortic valve stenosis (CAVS)[3].
    Menaquinone-7-13C6